# β2-Chimaerin Deficiency Favors Polyp Growth in the Colon of ApcMin/+ Mice

## TL;DR

This study shows that a lack of β2-chimaerin promotes colon polyp growth in mice, suggesting it may act as a tumor suppressor in colorectal cancer.

## Contribution

The study reveals a novel role of β2-chimaerin in suppressing colonic tumor growth through modulation of ERK signaling.

## Key findings

- β2-chimaerin deficiency increases colonic polyp growth in ApcMin/+ mice.
- Low β2-chimaerin expression correlates with poor prognosis in CRC patients.
- ERK phosphorylation is enhanced in the absence of β2-chimaerin, but Wnt/β-catenin and E-cadherin pathways remain unaffected.

## Abstract

A Rho-GTPases are pivotal regulators of key cellular processes implicated in colorectal cancer (CRC) progression, yet the roles of their regulatory proteins, particularly GTPase-activating proteins (GAPs), remain poorly understood. This study focuses on β2-chimaerin, a Rac1-specific GAP, in Apc-driven tumorigenesis using the ApcMin/+ mouse model. We demonstrate that β2-chimaerin deficiency selectively promotes the growth of colonic polyps without influencing small intestinal polyp formation. Mechanistically, β2-chimaerin loss is associated with enhanced ERK phosphorylation, while canonical Wnt/β-catenin and E-cadherin pathways remain unaffected, suggesting its specific involvement in modulating proliferative signaling in the colon. Consistent with its tumor-suppressive role, bioinformatics analyses reveal that low β2-chimaerin expression correlates with poor prognosis in CRC patients. This study expands the understanding of Rho-GTPase regulatory mechanisms in intestinal tumorigenesis, providing a basis for future therapeutic strategies targeting Rho-GTPase pathways in CRC.